M Küllmar1, M Meersch2. 1. Klinik für Anästhesiologie, operative Intensivmedizin und Schmerztherapie, Universitätsklinikum Münster, Albert-Schweitzer-Campus 1, Gebäude A1, 48149, Münster, Deutschland. 2. Klinik für Anästhesiologie, operative Intensivmedizin und Schmerztherapie, Universitätsklinikum Münster, Albert-Schweitzer-Campus 1, Gebäude A1, 48149, Münster, Deutschland. meersch@uni-muenster.de.
Abstract
BACKGROUND: Acute kidney injury (AKI) is a frequent complication in the perioperative period and is associated with a high morbidity and mortality. AKI is an independent risk factor for adverse outcome. The Kidney Disease: Improving Global Outcome (KDIGO) guidelines define AKI based on increases in serum creatinine and/or urinary output. Since there is no causal therapy available, early detection and timely implementation of preventive measures are of particular importance. OBJECTIVE: This article gives an overview of the disease picture of perioperative AKI. The recommendations on diagnostics, prevention and treatment are presented. METHODS: The available evidence is summarized based on the currently available literature. RESULTS: New renal biomarkers demonstrate kidney stress and are able to make an early prediction of the development of AKI. The implementation of the KDIGO bundles (discontinuation of all nephrotoxic medications, optimization of the volume status and perfusion pressure, consideration of an extended functional hemodynamic monitoring, close monitoring of serum creatinine concentration and urine output, avoidance of hyperglycemia and consideration of alternatives to radiocontrast agents) and remote ischemic preconditioning have shown a significant reduction in the incidence of AKI in high-risk patients. CONCLUSION: For timely diagnosis and prevention of AKI the recommendations for action of the KDIGO guidelines should be implemented. High-risk patients should be detected early in the perioperative period in order to be able to initiate preemptive strategies in a timely manner.
BACKGROUND:Acute kidney injury (AKI) is a frequent complication in the perioperative period and is associated with a high morbidity and mortality. AKI is an independent risk factor for adverse outcome. The Kidney Disease: Improving Global Outcome (KDIGO) guidelines define AKI based on increases in serum creatinine and/or urinary output. Since there is no causal therapy available, early detection and timely implementation of preventive measures are of particular importance. OBJECTIVE: This article gives an overview of the disease picture of perioperative AKI. The recommendations on diagnostics, prevention and treatment are presented. METHODS: The available evidence is summarized based on the currently available literature. RESULTS: New renal biomarkers demonstrate kidney stress and are able to make an early prediction of the development of AKI. The implementation of the KDIGO bundles (discontinuation of all nephrotoxic medications, optimization of the volume status and perfusion pressure, consideration of an extended functional hemodynamic monitoring, close monitoring of serum creatinine concentration and urine output, avoidance of hyperglycemia and consideration of alternatives to radiocontrast agents) and remote ischemic preconditioning have shown a significant reduction in the incidence of AKI in high-risk patients. CONCLUSION: For timely diagnosis and prevention of AKI the recommendations for action of the KDIGO guidelines should be implemented. High-risk patients should be detected early in the perioperative period in order to be able to initiate preemptive strategies in a timely manner.
Authors: Patrick Meybohm; Berthold Bein; Oana Brosteanu; Jochen Cremer; Matthias Gruenewald; Christian Stoppe; Mark Coburn; Gereon Schaelte; Andreas Böning; Bernd Niemann; Jan Roesner; Frank Kletzin; Ulrich Strouhal; Christian Reyher; Rita Laufenberg-Feldmann; Marion Ferner; Ivo F Brandes; Martin Bauer; Sebastian N Stehr; Andreas Kortgen; Maria Wittmann; Georg Baumgarten; Tanja Meyer-Treschan; Peter Kienbaum; Matthias Heringlake; Julika Schön; Michael Sander; Sascha Treskatsch; Thorsten Smul; Ewa Wolwender; Thomas Schilling; Georg Fuernau; Dirk Hasenclever; Kai Zacharowski Journal: N Engl J Med Date: 2015-10-05 Impact factor: 91.245
Authors: Charuhas V Thakar; Susana Arrigain; Sarah Worley; Jean-Pierre Yared; Emil P Paganini Journal: J Am Soc Nephrol Date: 2004-11-24 Impact factor: 10.121
Authors: Paul S Myles; Rinaldo Bellomo; Tomas Corcoran; Andrew Forbes; Philip Peyton; David Story; Chris Christophi; Kate Leslie; Shay McGuinness; Rachael Parke; Jonathan Serpell; Matthew T V Chan; Thomas Painter; Stuart McCluskey; Gary Minto; Sophie Wallace Journal: N Engl J Med Date: 2018-05-09 Impact factor: 91.245
Authors: Melanie Meersch; Christoph Schmidt; Hugo Van Aken; Sven Martens; Jan Rossaint; Kai Singbartl; Dennis Görlich; John A Kellum; Alexander Zarbock Journal: PLoS One Date: 2014-03-27 Impact factor: 3.240
Authors: Kianoush Kashani; Ali Al-Khafaji; Thomas Ardiles; Antonio Artigas; Sean M Bagshaw; Max Bell; Azra Bihorac; Robert Birkhahn; Cynthia M Cely; Lakhmir S Chawla; Danielle L Davison; Thorsten Feldkamp; Lui G Forni; Michelle Ng Gong; Kyle J Gunnerson; Michael Haase; James Hackett; Patrick M Honore; Eric A J Hoste; Olivier Joannes-Boyau; Michael Joannidis; Patrick Kim; Jay L Koyner; Daniel T Laskowitz; Matthew E Lissauer; Gernot Marx; Peter A McCullough; Scott Mullaney; Marlies Ostermann; Thomas Rimmelé; Nathan I Shapiro; Andrew D Shaw; Jing Shi; Amy M Sprague; Jean-Louis Vincent; Christophe Vinsonneau; Ludwig Wagner; Michael G Walker; R Gentry Wilkerson; Kai Zacharowski; John A Kellum Journal: Crit Care Date: 2013-02-06 Impact factor: 9.097